scispace - formally typeset
Journal ArticleDOI

Choosing an animal model for the study of Huntington's disease

TLDR
This Review provides an overview of the currently available animal models of HD in the context of the clinical features of the disease and highlights their strengths and limitations for modelling specific symptoms of the Disease.
Abstract
Since the identification of the causative gene in Huntington's disease (HD), a number of animal models of this disorder have been developed. A frequently asked question is: which of these models most closely recapitulates the human disease? In this Review, we provide an overview of the currently available animal models of HD in the context of the clinical features of the disease. In doing so, we highlight their strengths and limitations for modelling specific symptoms of the disease. This should highlight the animal model that is best suited to address a particular question of interest and, ultimately, to expedite the discovery of treatments that will prevent or slow the progression of HD.

read more

Citations
More filters
Journal ArticleDOI

Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice

TL;DR: It is found that symptom onset in R6/2 and Q175 HD mouse models was not associated with classical astrogliosis, but was associated with decreased Kir4.1 K+ channel functional expression, leading to elevated in vivo striatal extracellular K+, which increased MSN excitability in vitro.
Journal ArticleDOI

Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders

TL;DR: Evidence both supporting and refuting the localization hypothesis of NMDAR function is reviewed and the role of N MDAR localization in disorders of the nervous system is discussed, particularly in Alzheimer disease and Huntington disease.
Journal ArticleDOI

'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

TL;DR: The role of the circadian system in the regulation of the sleep–wake cycle is discussed, and the implications of disrupted circadian timekeeping in neurodegenerative diseases are outlined.
Journal ArticleDOI

Mutant Huntingtin Disrupts the Nuclear Pore Complex

TL;DR: This work evaluated the NPC and nucleocytoplasmic transport in multiple models of HD, including mouse and fly models, neurons transfected with mHTT, HD iPSC-derived neurons, and human HD brain regions, and revealed severe mislocalization and aggregation of NUPs and defective nucleocy toplasmi transport.
References
More filters
Journal ArticleDOI

Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

TL;DR: The GAL4 system, a system for targeted gene expression that allows the selective activation of any cloned gene in a wide variety of tissue- and cell-specific patterns, has been designed and used to expand the domain of embryonic expression of the homeobox protein even-skipped.
Journal ArticleDOI

Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice

TL;DR: Mice have been generated that are transgenic for the 5' end of the human HD gene carrying CAG/polyglutamine repeat expansion that exhibits many of the features of HD, including choreiform-like movements, involuntary stereotypic movements, tremor, and epileptic seizures.
Journal ArticleDOI

Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain

TL;DR: An NH2-terminal fragment of mutant huntingtin was localized to neuronal intranuclear inclusions and dystrophic neurites in the HD cortex and striatum, and polyglutamine length influenced the extent of huntingtin accumulation in these structures.
Journal ArticleDOI

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the hd mutation

TL;DR: In this paper, the authors observed that mice transgenic for exon 1 of the human HD gene carrying (CAG)115 to 157 repeat expansions develop pronounced neuronal intranuclear inclusions, containing the proteins huntingtin and ubiquitin, prior to developing a neurological phenotype.
Journal ArticleDOI

Huntington's disease.

TL;DR: Effective intervention by clinicians is possible in terms of providing patients and families with accurate information about the disease, counseling them about availability of genetic testing at specialized centers, and in giving them sound advice regarding work, driving, relationships, finances, research participation, and support groups.
Related Papers (5)